Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crossroads Treatment Centers is a leading provider of substance use disorder treatment services, specializing in outpatient medication-assisted treatment (MAT) for opioid use disorder. Founded in 2005 and headquartered in Greenville, South Carolina, the company operates a network of over 100 clinics across the United States. Their clinical model combines FDA-approved medications, such as methadone and buprenorphine, with professional counseling and toxicology services to support long-term recovery. The organization is backed by Revelstoke Capital Partners and has grown significantly to become one of the largest providers of its kind in the country. Crossroads focuses on providing accessible, high-quality care to underserved populations affected by the opioid epidemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crossroads Behavioral Healthcare.